Moderna (NASDAQ:MRNA | MRNA Price Prediction) shares have crashed 20% as of 12:00 PM ET on Thursday after delivering one of ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Moderna, Inc. (NASDAQ: MRNA) today announced ...

Moderna Inc. MRNA stock is trading lower after it rallied around 170% on Wednesday on upbeat data from individualized cancer ...

Moderna has now swung violently in both directions for three straight sessions on the same unchanged clinical news, and the ...

“It’s very exciting,” a melanoma expert said of the experimental cancer vaccine announced by pharmaceutical companies Moderna ...

Investors had been pessimistic about the probability of success for the personalized cancer vaccine intismeran autogene, so ...

Merck MRK is increasingly relying on the growing portfolio of newer products, recent acquisitions and pipeline candidates to ...

Merck (MRK) stock slips as RBC Capital Markets cuts on valuation while Morgan Stanley upgrades on trial data for Moderna ...

MRK's Keytruda remains a key growth engine in 2026, but patent loss and rising competition could challenge its long-term ...

Nevertheless, in the past year, Merck (MRK) delivered an impressive 73% return to investors, outpacing the S&P 500. The peak ...

Merck CEO Rob Davis said the drugmaker has evolved beyond Keytruda, with more than 20 potential blockbuster launches over the ...